IL-15 receptor
Assets acting on this target.
- Class
- IL-15 receptor agonist
- Notes
- mechanism wave 2026-08-24 (DeepSeek draft; registry text of NCT03233854 names the target); source: https://clinicaltrials.gov/study/NCT03233854
IL-15 receptor drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| RC198 | RemeGen Co., Ltd. | fusion protein | Phase 1 | Phase 1 in Non-Small Cell Lung Cancer |
| Avipendekin pegol | Nektar Therapeutics | cytokine | Stage not recorded | Not recorded |